ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2550

Development of a ‘Training Toolkit’ to Support Advanced Practice Providers (APPs) Entry into a Rheumatology Musculoskeletal Ultrasound Subspecialty Clinic

Christopher Estes1, Janeth Yinh1, Mark Matza2, Marcy Bolster3 and Minna Kohler4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Newton, MA, 3Massachusetts General Hospital, Concord, MA, 4Massachusetts General Hospital, Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Access to care, Education, education, medical, Ultrasound, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2547–2566) ARP Posters I

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The integration of advanced practice providers (APPs) into rheumatology practice may help address increasing demand and long wait times.1 However, outcome data on APP involvement, particularly in procedural roles, remain limited. We report how ultrasound (US)-guided procedures performed by a newly hired APP in a high-volume, procedure-focused rheumatology musculoskeletal (MSKUS) clinic can enhance patient access to diagnostic and therapeutic interventions. 

Methods: CPT codes for US-guided procedures performed by a newly hired APP were tracked over a 7-month period (8/2023–3/2024). Prior to this period, the APP had 1 year of experience performing palpation-guided injections and completed a rheumatologic MSKUS training program emphasizing procedural guidance. The APP performed over 100 US-guided procedures under direct supervision before transitioning to independent practice. Procedures included US-guided aspiration and/or corticosteroid injection. CPT codes were used to classify procedures sites with US-guidance: large joint/bursa (20611), intermediate joint/bursa (20606), small joint (20604), tendon sheath (20550), and carpal tunnel (20526). Data were analyzed by frequency and percentage of total procedures performed. Associated clinical diagnoses were also collected.  

Results: Over the 7-month period, the APP performed a total of 284 US guided procedures during independently scheduled procedure clinics.  Of these, 59% (n=167) were large joints/bursae, 11% (n=32) involved intermediate joints/bursae, 25% (n=70) were small joint injections, 2% (n=7) involved tendon sheaths, and 3% (n=8) were carpal tunnel injections (Fig. 1). Indications for procedures included joint effusion, synovitis, bursitis, tendinitis and carpal tunnel syndrome. Underlying diagnoses among patients included inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, spondylarthritis), crystalline arthritis (gout, calcium pyrophosphate deposition disease), osteoarthritis, and mechanical overuse syndromes. Patient access improved to less than 2 weeks. 

Conclusion: In an early implementation phase, the majority of US-guided procedures performed by a novice APP involved large joints (e.g. shoulders, hips, and knees) and small joints (e.g. MCP, MTP, PIP), with large joints comprising over half of all procedures. These findings guide referral planning and scope expectations for APPs new to a rheumatology MSKUS procedure clinic. Ongoing assessments will evaluate the evolution of procedure types and volumes over time as the APP gains experience, providing further insight into the scope and capacity of APPs in performing US-guided procedures within rheumatology practice demonstrating impact on rheumatology workforce expansion and patient access. 

Supporting image 1Table 1

Supporting image 2


Disclosures: C. Estes: None; J. Yinh: Janssen, 2, Springer, 9; M. Matza: Expert Review, 12,, Novartis, 1, Summus Global, Inc, 2, USSONAR, 6; M. Bolster: Genentech, 5, Mitsubishi, 5, Prometheus, 5; M. Kohler: Janssen, 5, 12, medical advisory board, Novartis, 12, medical advisory board, Setpoint Medical, 5, Springer Publications, 9.

To cite this abstract in AMA style:

Estes C, Yinh J, Matza M, Bolster M, Kohler M. Development of a ‘Training Toolkit’ to Support Advanced Practice Providers (APPs) Entry into a Rheumatology Musculoskeletal Ultrasound Subspecialty Clinic [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/development-of-a-training-toolkit-to-support-advanced-practice-providers-apps-entry-into-a-rheumatology-musculoskeletal-ultrasound-subspecialty-clinic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-training-toolkit-to-support-advanced-practice-providers-apps-entry-into-a-rheumatology-musculoskeletal-ultrasound-subspecialty-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology